Skip to main content
Michael Epstein, MD, Gastroenterology, Annapolis, MD

MichaelSamuelEpsteinMD

Gastroenterology Annapolis, MD

Physician

Dr. Epstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Epstein's full profile

Already have an account?

  • Office

    621 Ridgely Ave
    Ste 201
    Annapolis, MD 21401
    Phone+1 410-224-4887
    Fax+1 410-224-1428

Education & Training

  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalFellowship, Gastroenterology, 1984 - 1986
  • George Washington University
    George Washington UniversityResidency, Internal Medicine, 1981 - 1984
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1981

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1986 - 2026
  • FL State Medical License
    FL State Medical License 2014 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Fellow (AGAF) American Gastroenterological Association, 2007
  • Fellow (FACG) American College of Gastroenterology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • 36-Month Post-Marketing Surveillance Report for FDgard®, Now Available for Review at the American College of Gastroenterology (ACG) E-poster Website
    36-Month Post-Marketing Surveillance Report for FDgard®, Now Available for Review at the American College of Gastroenterology (ACG) E-poster WebsiteOctober 26th, 2020
  • For the Sixth Year in A Row, in A Survey of Gastroenterologists' Preferences for IBS Products, IBgard® Widens Its Already Preeminent "#1 Recommended"[1] Status
    For the Sixth Year in A Row, in A Survey of Gastroenterologists' Preferences for IBS Products, IBgard® Widens Its Already Preeminent "#1 Recommended"[1] StatusAugust 10th, 2020
  • Unprecedented 3-Year Safety Data Unveiled at Digestive Disease Week (DDW) Indicates No Pattern of Heartburn with IBgard®, an Advanced Technology Peppermint Oil, Contrary to Heartburn Issues with Older Technologies
    Unprecedented 3-Year Safety Data Unveiled at Digestive Disease Week (DDW) Indicates No Pattern of Heartburn with IBgard®, an Advanced Technology Peppermint Oil, Contrary to Heartburn Issues with Older TechnologiesMay 5th, 2020
  • Join now to see all

Professional Memberships